|
Re: Pattern of recurrence of early bc differs by intrinsic subtype & proliferation in
Ellie,
Well . . . not exactly grasped, lol.
Yes, the Her2 positive, ER-, PR- is the Her2 enriched classification.
I think the idea of a booster of Herceptin is very sound. But an entire year of Herceptin at 6 years would likely be a little late and way too much treatment.
What is more practical is to have boosters that would precede the recurrence patterns in the subtypes. So if one is likely to recur at 24 months, the booster should be before to block that pathway and prevent the cancer from growing.
The concept of boosters of targeted therapies could be a game changer!!!! Yeah!
Last edited by 'lizbeth; 10-25-2013 at 12:00 PM..
Reason: Emphasis!
|
Hybrid Mode
